News

By creating a cohesive AI-enabled and physics-based molecular modeling and drug discovery pipeline built around film industry animation software, researchers at the Wyss Institute at Harvard ...
Scientists at Northwestern University have developed the largest open-access resource of its kind to help researchers shave ...
“It is a privilege to welcome Claire to our Board, where she will draw from her strategic and operational experience in clinical-stage oncology to offer guidance as we prepare to initiate our Phase 3 ...
The new multiyear agreement will allow the Danish pharma to use Gefion’s computational power to “process vast datasets” with ...
DCAI today announced that Novo Nordisk has become a customer of the Gefion AI supercomputer. Through this agreement, Novo Nordisk will gain access to Gefion's unparalleled computational capabilities ...
Recursion's AI-enabled drug discovery platform continues to evolve, but this is yet to translate into meaningful clinical ...
AI will greatly lessen the effort of the discovery process, bringing more novel therapies to the forefront faster than ever ...
In JAMA, the FDA's Makary and Prasad said they will focus on modernizing review processes and lowering drug costs but don't outright mention precision medicine.
In March, the journal Nature published the discoveries of two paradigm-breaking antimicrobial compounds in as many weeks: a ...
JUNE 10, 2025 — UTSA researchers in the Max and Minnie Tomerlin Voelcker CIDD Preclinical Pharmacology Core for Accelerated ...